CE CREDITS ARE NOW AVAILABLE FOR DM EDUCATEä, COMPREHENSIVE ONLINE DIABETES MANAGEMENT COURSE

Test Your Knowledge Issue 369

In patients with type 2 diabetes, the risk of a first coronary heart disease (CHD) event depends on a number of factors, including sex, age, and microvascular disease, as well as glycemic control and dyslipidemia.

An experimental drug prevented mice from developing diabetes and heart disease and might one day be used to stave off the diseases in humans, U.S. researchers said last week.

Insufficient numbers of women who had gestational diabetes during pregnancy are being screened for diabetes in the first year postpartum, according to a retrospective study.

In a blow to the drug maker and millions of overweight and obese Americans hoping for a new weight-loss medication, the FDA's Endocrinologic and Metabolic Drugs Advisory Committee unanimously told Sanofi-Aventis to gather more detailed safety...

Published results from a 447 subject, randomized, double-blind, placebo-controlled clinical study showed Diachrome®, a patented combination of chromium picolinate and biotin, significantly improved glycemic control in patients with poorly controlled...

The advanced glycation end product inhibitor LR-90 has anti-inflammatory properties that may protect against diabetic vascular complications.

Acanthosis nigricans is an independent risk factor for type 2 diabetes, and its presence may help primary care clinicians identify high-risk patients with diabetes sooner, according to the results of a cross-sectional study.

Nonalcoholic fatty liver disease (NAFLD) is common in type 2 diabetes patients and is associated with a high prevalence of cardiovascular disease (CVD), according to new findings.

Patients with type 2 diabetes who have periodontitis are more likely than other diabetic patients to develop kidney disease, including end-stage renal failure.

Obesity, metabolic syndrome traits, and parental diabetes predict the development of type 2 diabetes in middle-aged adults.

The synthetic form of a hormone previously found to produce a feeling of fullness when eating and reduce body weight, also may help curb binge eating and the desire to eat high-fat foods and sweets.

A controlled release formulation of topiramate is effective adjunctive therapy for weight loss in obese type 2 diabetics treated with diet and exercise alone or in combination with metformin, researchers report in the June issue of Diabetes Care.

Simple, stupid: Too much TV, sedentary lifestyle and not meeting public health recommendations for physical activity.

Before heart disease even develops among patients with heart disease, the effects on life expectancy have already begun, found researchers.

People who are obese at age 18 will more likely than not develop type 2 diabetes at some point, according to a U.S. study.

Last time Richard K. Bernstein, M.D., F.A.C.E., F.A.C.N., C.W.S. helped us understand the effects of Avandia on the cardiovascular system, this week he looks at Restrictions On Salt Intake: Are They Reasonable For All Diabetics?